Standard BioTools Statistics

Total Valuation

LAB has a market cap or net worth of $972.94 million. The enterprise value is $956.26 million.

Market Cap	972.94M
Enterprise Value	956.26M

Important Dates

The next estimated earnings date is Tuesday, May 7, 2024, after market close.

Earnings Date	May 7, 2024
Ex-Dividend Date	n/a

Share Statistics

LAB has 383.05 million shares outstanding. The number of shares has increased by 1.09% in one year.

Shares Outstanding	383.05M
Shares Change (YoY)	+1.09%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	0.69%
Owned by Institutions (%)	56.07%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.15
Forward PS	4.82
PB Ratio	n/a
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	8.99
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 1.45

Current Ratio	1.45
Quick Ratio	1.23
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-15.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-21.50%
Return on Capital (ROIC)	n/a
Revenue Per Employee	$199,139
Profits Per Employee	-$139,805
Employee Count	534
Asset Turnover	0.31
Inventory Turnover	2.66

Taxes

In the past 12 months, LAB has paid $452,000 in taxes.

Income Tax	452,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +41.90% in the last 52 weeks. The beta is 1.64, so LAB's price volatility has been higher than the market average.

Beta (1Y)	1.64
52-Week Price Change	+41.90%
50-Day Moving Average	2.59
200-Day Moving Average	2.41
Relative Strength Index (RSI)	41.34
Average Volume (30 Days)	2,004,225

Short Selling Information

The latest short interest is 10.23 million, so 2.67% of the outstanding shares have been sold short.

Short Interest	10.23M
Short Previous Month	9.26M
Short % of Shares Out	2.67%
Short % of Float	n/a
Short Ratio (days to cover)	5.06

Income Statement

In the last 12 months, LAB had revenue of $106.34 million and -$74.66 million in losses. Loss per share was -$0.94.

Revenue	106.34M
Gross Profit	50.45M
Operating Income	-76.60M
Pretax Income	-74.20M
Net Income	-74.66M
EBITDA	-65.66M
EBIT	-69.64M
Loss Per Share	-$0.94

Full Income Statement

Balance Sheet

The company has $114.90 million in cash and $98.21 million in debt, giving a net cash position of $16.69 million or $0.04 per share.

Cash & Cash Equivalents	114.90M
Total Debt	98.21M
Net Cash	16.69M
Net Cash Per Share	$0.04
Equity / Book Value	-148.05M
Book Value Per Share	-0.39
Working Capital	48.89M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$43.29 million and capital expenditures -$2.83 million, giving a free cash flow of -$46.12 million.

Operating Cash Flow	-43.29M
Capital Expenditures	-2.83M
Free Cash Flow	-46.12M
FCF Per Share	-$0.58

Full Cash Flow Statement

Margins

Gross margin is 47.44%, with operating and profit margins of -72.03% and -70.21%.

Gross Margin	47.44%
Operating Margin	-72.03%
Pretax Margin	-69.78%
Profit Margin	-70.21%
EBITDA Margin	-61.74%
EBIT Margin	-65.49%
FCF Margin	-43.37%

Dividends & Yields

LAB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1.09%
Shareholder Yield	-1.09%
Earnings Yield	-7.67%
FCF Yield	-4.74%

Analyst Forecast

The average price target for LAB is $3.58, which is 40.95% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$3.58
Price Target Difference	40.95%
Analyst Consensus	Strong Buy
Analyst Count	3
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

LAB has an Altman Z-Score of -0.89 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.89
Piotroski F-Score	4